University of North Carolina
Chapel Hill, North Carolina, 27599, United States
NCT Number: NCT02306252
The CARE Program is a randomized trial of a cancer rehabilitation program designed to help older cancer patients who have shown to have a loss of function.
Looking for future studies?
Notify MeThis is a prospective, two-arm, single-center randomized controlled pilot trial of a cancer rehabilitation program for older adults, titled the 'CARE program,' which is designed to maintain and/or improve functional status and quality of life in older adults diagnosed with cancer. Adults aged 65 years and older with cancer will be screened with a Geriatric Assessment (GA) for eligibility. Although breast cancer patients will be eligible, this study will focus primarily on other types of cancers. Adults with at least one functional deficit --defined as impairment in ability to perform activities of daily living or instrumental activities of daily living, cognitive decline or balance -- will be randomized to either the intervention (CARE program) or to the control arm (Supportive care services information only). Both arms will receive a brochure about the supportive care program to provide patients who we've identified as having deficits with information about auxiliary services available and because the intent is to limit the difference between the groups. We hypothesize that patients who participate in the CARE program will maintain or improve functional status and quality of life when compared to supportive care services information only.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
OT and PT will be arranged for the subject and conducted in a manner as determined by the therapist.
Time frame: 3 months
Compare the change in NEADL scores from baseline to 3 months between patients who receive the CARE program (intervention) and those in the control arm.
Time frame: 2 months
As measured by the Geriatric Assessment
Time frame: 3 months
As measured by the Geriatric Assessment
Time frame: 3 months
As measured by the Geriatric Assessment
Time frame: 2 months
As measured by the Geriatric Assessment
Time frame: 2 months
As measured by the PROMIS assessment
Time frame: 3 months
As measured by the PROMIS assessment
Time frame: 3 months
As measured by the Possibilities for Activity Scale (PActS)
Time frame: 2 months
As measured by the Possibilities for Activity Scale (PActS)
Time frame: 2 months
As measured by the Blessed Memory Orientation Concentration test
Time frame: 3 months
As measured by the Blessed Memory Orientation Concentration test
Time frame: 3 months
To describe the feasibility of the CARE program by reporting enrollment and retention as defined by (1) percent eligible who agree to participate (2) percent in each group that completed follow-up measures at 2 and 3 months and (3) percent of patients in CARE program who go to 70% of appointments.
Time frame: 3 months
Intervention Group Only: As measured by the Berg Balance Scale
Time frame: 3 months
Intervention Group Only: As measured by the Disability of the Arm, Shoulder and Hand scale
Time frame: 3 months
Intervention Group Only: As measured by the Montreal Cognitive Assessment
Time frame: 3 months
Intervention Group Only: As measured by the Dynamic Gait Index
Time frame: 3 months
To evaluate the program a short interview will be completed with CARE team to determine what worked well, what didn't and suggested changes/improvements for CARE program after completion of project.
UNC Lineberger Comprehensive Cancer Center
Other
LCCC 1409: The CARE Program: CAncer REhabilitation Pilot Study for Older Adults
Acronym: CARE Program
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06493682
Behavior, Cancer
Amasya, Turkey (Türkiye)
View Trial DetailsNCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT01445483
Brain Diseases, Brain Metastasis
Bethesda, Maryland, United States
View Trial DetailsNCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial Details